Regulation of complement C3 expression by the bile acid receptor FXR

被引:84
作者
Li, JL [1 ]
Pircher, PC [1 ]
Schulman, IG [1 ]
Westin, SK [1 ]
机构
[1] X Cepto Therapeut, Dept Biol, San Diego, CA 92121 USA
关键词
D O I
10.1074/jbc.M411473200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The farnesoid X receptor ( FXR; NR1H4) is an intracellular bile acid-sensing transcription factor that plays a critical role in the regulation of synthesis and transport of bile acids as well as lipid metabolism. Although the reciprocal relationship between bile acid and triglyceride levels is well known, the mechanism underlying this link is not clearly defined. In this study, we demonstrate that FXR regulates the expression of at least two secreted factors, complement component C3 and FGF15, the rat ortholog of FGF19, known to influence lipid metabolism. The analysis of the human complement C3 gene reveals the presence of functional FXR response elements in the proximal promoter of C3. Furthermore, rats given a single dose of an FXR agonist exhibit an increase in the plasma concentration of complement C3 protein. These studies demonstrate a mechanism by which FXR, a nuclear receptor with a limited tissue expression pattern, regulates secretion of factors that ultimately can affect lipid metabolism in an endocrine or paracrine manner.
引用
收藏
页码:7427 / 7434
页数:8
相关论文
共 39 条
[1]
HUMAN C'3 - EVIDENCE FOR LIVER AS PRIMARY SITE OF SYNTHESIS [J].
ALPER, CA ;
JOHNSON, AM ;
BIRTCH, AG ;
MOORE, FD .
SCIENCE, 1969, 163 (3864) :286-&
[2]
Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor [J].
Ananthanarayanan, M ;
Balasubramanian, N ;
Makishima, M ;
Mangelsdorf, DJ ;
Suchy, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :28857-28865
[3]
ANGELIN B, 1978, J LIPID RES, V19, P1017
[4]
Auwerx J, 1999, CELL, V97, P161
[5]
FXR induces the UGT2B4 enzyme in hepatocytes: A potential mechanism of negative feedback control of FXR activity [J].
Barbier, O ;
Torra, IP ;
Sirvent, A ;
Claudel, T ;
Blanquart, C ;
Duran-Sandoval, D ;
Kuipers, F ;
Kosykh, V ;
Fruchart, JC ;
Staels, B .
GASTROENTEROLOGY, 2003, 124 (07) :1926-1940
[6]
Barnum S R, 1989, Year Immunol, V6, P208
[7]
CHENODEOXYCHOLIC ACID THERAPY FOR HYPERTRIGLYCERIDEMIA IN MEN [J].
BATESON, MC ;
MACLEAN, D ;
EVANS, JR ;
BOUCHIER, IAD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (03) :249-254
[8]
Increased expression of complement component C3 in the plasma of obese Zucker fa and LA/N faf rats compared with their lean counterparts [J].
Boggs, RD ;
McCumbee, WD ;
Cobbs, SL ;
Todd, DG ;
Kahle, EB ;
Stewart, NL ;
Bailey, M ;
Reichenbecher, VE .
OBESITY RESEARCH, 1998, 6 (05) :361-367
[9]
Influence of C3 deficiency on atherosclerosis [J].
Buono, C ;
Come, CE ;
Witztum, JL ;
Maguire, GF ;
Connelly, PW ;
Carroll, M ;
Lichtman, AH .
CIRCULATION, 2002, 105 (25) :3025-3031
[10]
Nuclear receptors and lipid physiology: Opening the X-files [J].
Chawla, A ;
Repa, JJ ;
Evans, RM ;
Mangelsdorf, DJ .
SCIENCE, 2001, 294 (5548) :1866-1870